Dear FACCNE Members, Partners and Friends,

As 2024 just started, we would like to take a moment to express our deep gratitude. Your valuable commitment and trust contribute significantly to our growth and success. In 2023, FACCNE exceeded its expected goals and reached results never seen before since its inception almost 40 years ago. Thank you!

As our community eagerly anticipates upcoming events, both seasoned and new members are encouraged to share their success stories and expertise, fostering a spirit of collaboration and celebration within FACCNE. A few examples are displayed in this first newsletter of the year.

On behalf of the FACCNE Board and Team, we would like to extend our warmest wishes for a successful and prosperous year. We can't wait to see what lies ahead for 2024!

Happy reading!


MIGSO-PCUBED opens an office in Boston

"MIGSO-PCUBED is delighted to become a member of FACCNE. As a multinational company headquartered in France with a growing hub in Boston, we are thrilled to become a part of the French American community of New England.


MIGSO-PCUBED specializes in Project Management and PMO consulting. With our team around the globe, we have become the trusted delivery partner for the most recognizable brands, many of whom are also well-established in New England.


Especially in the Life Sciences, Energy, and Aerospace sectors, we help our clients to turn their biggest ideas into reality by adapting our solutions to their culture and by leveraging the latest technologies and best practices to do so.


We are eager to support business growth in the region and look forward to making great connections in the process!"

Meet the Team in Boston:

Olivia Laureau Cherif

Business Unit Manager

Adam Robberts

Business Manager

Upcoming Events

FACCNE Annual Meeting

📅 Wednesday, January 24

⏰ 6:00 - 8:00 PM

📍 IPSEN, Kendall Square



An AI-Powered Workforce

📅 Tuesday, January 30

⏰ 6:00 - 8:00 PM

📍 EY, 200 Clarendon St, Boston

🤝 Open to All ; Discount for FACCNE Members


Café des Sciences with Nadine Beauger

📅 Wednesday, February 7

⏰ 6:00 - 8:00 PM

📍 CIC Cambridge @ 1 Broadway

🤝Open to All ; Free and in French


Annual 2024 GBANE Event

📅 Tuesday, February 27

⏰ 5:30 - 8:00 PM

📍 Suffolk University Law School, 120 Tremont Street Boston, MA 02108

🤝 Open to All


Members and Partners' News

The application is now open to present at Align Summit 2024a day-long innovation partnering event that connects 300+ industry investors with the best and brightest startups and small companies in the life sciences.

This year’s Align Summit on April 25, 2024 in Cambridge, Massachusetts will showcase innovative seed to series A biotechs as well as private companies working on AI and ML in drug discovery and development. To learn more about this opportunity and apply to present, complete the presenter interest form by January 12, 2024 at 12:00PM (noon) ET.

Apply to Align Summit here 

Accelerate your therapeutic or biotech platform with the support of MassBioDrive, a hybrid startup accelerator designed to support early-stage biotechs and scientific founders. Over the course of a tailored 8-week program, founders get access to business fundamental curriculum, mentorship, industry connections, and equity-free cash prizes – all entirely free of cost to participants. To learn more, visit https://bit.ly/MBD2024 & apply for the S24 cohort by January 27, 2024 at 12:00PM (noon) ET.

Apply to MassBioDriv 

FEI's Annual Economic Outlook

Join them for a thought-provoking and informative breakfast event as they explore the economic outlook for 2024. Understanding economic trends and forecasts is crucial for making informed decisions and seizing opportunities in an ever-changing global landscape.

Their event will feature a blend of networking and a dynamic panel discussion, bringing together experts and professionals from diverse fields to provide valuable insights into what lies ahead for the economy in 2024. Whether you are a business owner, investor, or simply interested in staying informed, this event is a must-attend for anyone looking to gain a competitive edge in the coming year.


7:00 AM- 7:45 AM: Registration and networking

7:45 AM - 8:45 AM: Economic panel discussion and audience Q&A

8:45 AM- 9:30 AM: Additional networking

Join Here


Solving the developability challenges

of New Chemical Entities

Solving the developability challenges of New Chemical Entities for oral formulation: Innovation towards a successful development of drug candidates


Oral drug formulation remains the preferred and most economical administration form to guarantee a successful commercialization. However, 90% of New Chemical Entities are poorly water soluble, which makes oral forms development a challenge. A robust methodology allows to move assets through preclinical phase to First-in-Human formulations with speed and confidence.


During this webinar, they will present the specific challenges encountered by Biotech companies when developing New Chemical Entities from Discovery phase to Early Clinical phases. A case study will be presented on an API presenting a low water solubility and at the same time a low solubility in lipophilic solvents. By selecting and implementing the right approach, the water solubility of the formulated API was increased by a factor 40. This approach, based on the physico-chemical and biological characteristics of the API to design a tailored solution, eases and accelerates the development of Early Clinical Formulations.


During this webinar you will learn:

- How to assess the developability of small molecules beyond Lipinski’s rule-of-five as oral drugs

- How pre-formulation allows to identify improvements around the API for formulation development

- How to identify early on Bioavailability challenges based on the physico-chemical and biological properties of the API

- How to choose the right technique depending on API characteristics

Date: Thursday 25th of January. 2024, 5:00pm - 5:45pm (CET)

Location: Online


o  Gautier Decock, PhD, CRDO Managing Director at Seqens

o  Sonia Lombardo, PhD, Preformulation Engineer Solid State at Seqens

For Registration, Click Here

EFOR is thrilled to launch their first (FREE!) webinar series for their US customers on how to certify medical devices in Europe. 


The application of Medical Device Regulation (MDR) 2017/745 has imposed more stringent requirements on medical device manufacturers seeking to sell and distribute their devices in Europe. 

Their three-part webinar series “CERTIFYING MEDICAL DEVICES IN EUROPE” seeks to address four elements of CE-mark submissions that are challenging for manufacturers:

  • Regulatory requirements of MDR 2017/745
  • Biocompatibility and toxicological evaluations
  • Usability requirements 
  • Clinical evaluations and post-market clinical follow-up

Each webinar will explore the requirements imposed by MDR 2017/745 and how manufacturers must demonstrate compliance with these requirements.

Each webinar will be followed by a question-and-answer session – so come prepared with all of your questions!


Join them in their Boston offices (space is limited) or online from 9:30am to 11:00am EST on:

  • January 18, 2024: Understanding the requirements of the new Medical Device Regulation

  • January 25, 2024: Understanding biocompatibility, toxicology and usability requirements of MDR 2017/745

  • February 1, 2024: Understanding the clinical evaluation requirements of MDR 2017/745


Interested ? Join their experts Yannick SPENNINCK, Technical Director North America, Iphigénie HUSSON, Technical Expert Regulatory Affairs, Eléonore MICHEL, Technical Expert and Manager in biological evaluations and toxicology, Jean-Charles DOMENGET, Technical Expert in Usability of medical devices, and Katharina HOEGL, Technical Expert and Manager in clinical evaluations. 

For Free Registration, Click Here

Join them for their January Virtual Open Houses! This is an excellent opportunity for you to gain insights into their educational programs, meet their staff and faculty, and explore the enriching learning environment they provide for their students.

The deadline for submitting applications for the 2024-25 academic year is Thursday, February 15th. They encourage you to promptly complete the application process to ensure your child's eligibility for the upcoming school year.

Register Here


FACC now sponsors the J1 Visa for Hospitality and Tourism!

👉 If you have any questions about sponsoring Talents in Hospitality and Tourism, please get in touch with us at: contact@faccne.org

Get in Touch

Job Opportunities

Sales Representative - On-Site & Travel Needed

Accounting Branch Manager - French fluency required

Supply Chain Consulting Manager - Boston, MA

Membership and Projects Coordinator - Boston, MA

Quick link to FACCNE job board

OVH - Alternatives Cloud Providers

Organizations are taking a "cloud-first" approach to digital transformation initiatives, which requires building, maintaining and operating a developer-ready infrastructure. TechTarget's Enterprise Strategy Group (ESG) conducted a comprehensive survey of 300 IT decision-makers across North America. ESG's findings underscore the growing prominence of alternative cloud options like OVHcloud®.

We encourage you to explore ESG's Alternative Cloud eBook and delve deeper into these findings.

Download your copy 

Inscription consulaire au registre des Français établis hors de France

Here are 5 compelling reasons to sign up at the consular register:

✅ More registrants mean more services available.

✅ Simplified procedures (facilitating passport and national identity card issuance, reducing the cost of certain administrative documents, etc.).

✅ Security

✅ Voting in French elections

✅ For your children (census, school scholarships, etc.)

So, what are you waiting for?

Register today - it's simple, free, and fast!

Register Now

Access to the FACCNE New Private Space

Follow us on LinkedIn

Join our 3,100+ followers on LinkedIn,

and don't miss any of our news!

Follow us here!

Stay connected

LinkedIn  Facebook  X